TickerFactsScreenerDevelopers

Ernexa Therapeutics Inc. (ERNA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $3.64M2010: $3.91M2011: $1.37M2012: $2.72M2013: $5.46M2014: $7.18M2015: $3.22M2016: $5.69M2017: $3.38M2018: $2.54M2019: $3.21M2020: $777.0K2021: $16.98M2022: $11.45M2023: $7.58M2024: $1.73M$1.73M
2009Cash & Equivalents (USD)2024
Fiscal YearCash & EquivalentsChange YoY
2024$1.73M-77.2%
2023$7.58M-33.8%
2022$11.45M-32.6%
2021$16.98M+2086.0%
2020$777.0K-75.8%
2019$3.21M+26.5%
2018$2.54M-24.9%
2017$3.38M-40.6%
2016$5.69M+76.4%
2015$3.22M-55.1%
2014$7.18M+31.7%
2013$5.46M+100.5%
2012$2.72M+98.0%
2011$1.37M-64.8%
2010$3.91M+7.4%
2009$3.64M—